Literature DB >> 18299872

Clinically based comments on the proposal for revision of the European Laryngological Society (ELS) classification of endoscopic cordectomies.

Marco Lucioni, Gino Marioni.   

Abstract

Mesh:

Year:  2008        PMID: 18299872     DOI: 10.1007/s00405-008-0607-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


× No keyword cloud information.
  3 in total

1.  Endoscopic cordectomy. A proposal for a classification by the Working Committee, European Laryngological Society.

Authors:  M Remacle; H E Eckel; A Antonelli; D Brasnu; D Chevalier; G Friedrich; J Olofsson; H H Rudert; W Thumfart; M de Vincentiis; T P Wustrow
Journal:  Eur Arch Otorhinolaryngol       Date:  2000       Impact factor: 2.503

Review 2.  Primary treatment of the anterior vocal commissure squamous carcinoma.

Authors:  Patrick J Bradley; Alessandra Rinaldo; Carlos Suárez; Ashok R Shaha; C René Leemans; Johannes A Langendijk; Snehal G Patel; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-08-15       Impact factor: 2.503

3.  Proposal for revision of the European Laryngological Society classification of endoscopic cordectomies.

Authors:  Marc Remacle; Christophe Van Haverbeke; Hans Eckel; Patrick Bradley; Dominique Chevalier; Votko Djukic; Marco de Vicentiis; Gerhard Friedrich; Jan Olofsson; Giorgio Peretti; Miquel Quer; Jochen Werner
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-03-22       Impact factor: 3.236

  3 in total
  2 in total

1.  Reply to the letter to the editor by Lucioni and Marioni: "Clinically based comments on the proposal for revision of the European Laryngological Society (ELS) classification of endoscopic cordectomies".

Authors:  Marc Remacle
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06-17       Impact factor: 2.503

2.  Glottic laser surgery: outcomes according to 2007 ELS classification.

Authors:  Marco Lucioni; Gino Marioni; Andy Bertolin; Luciano Giacomelli; Giuseppe Rizzotto
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-19       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.